Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data

BMC Infectious Diseases

Stephanie R Bialek²  Scott D Grosse¹  Michael J Cannon¹  Jessica Leung² 

[1]National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, USA

[2]National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, USA

关键词: Laboratory testing;    Screening;    Pregnant women;    MarketScan;    Cytomegalovirus;    CMV;   

Others  :  1158757
DOI  :  10.1186/1471-2334-12-334

 received in 2012-06-20, accepted in 2012-11-23,  发布年份 2012

【 摘 要 】

Background

Routine cytomegalovirus (CMV) screening during pregnancy is not recommended in the United States and the extent to which it is performed is unknown. Using a medical claims database, we computed rates of CMV-specific testing among pregnant women.

Methods

We used medical claims from the 2009 Truven Health MarketScan® Commercial databases. We computed CMV-specific testing rates using CPT codes.

Results

We identified 77,773 pregnant women, of whom 1,668 (2%) had a claim for CMV-specific testing. CMV-specific testing was significantly associated with older age, Northeast or urban residence, and a diagnostic code for mononucleosis. We identified 44 women with a diagnostic code for mononucleosis, of whom 14% had CMV-specific testing.

Conclusions

Few pregnant women had CMV-specific testing, suggesting that screening for CMV infection during pregnancy is not commonly performed. In the absence of national surveillance for CMV infections during pregnancy, healthcare claims are a potential source for monitoring practices of CMV-specific testing.

【 授权许可】

   
2012 Leung et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Dollard SC, Grosse SD, Ross DS: New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17(5):355-363.
• [2]Kenneson A, Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17(4):253-276.
• [3]Enders G, Daiminger A, Bader U, Exler S, Enders M: Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011, 52(3):244-246.
• [4]Yinon Y, Farine D, Yudin MH: Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 2010, 65(11):736-743.
• [5]Bate SL, Dollard SC, Cannon MJ: Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 2010, 50(11):1439-1447.
• [6]Colugnati FA, Staras SA, Dollard SC, Cannon MJ: Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007, 7:71. BioMed Central Full Text
• [7]Nigro G, Adler SP: Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 2011, 23(2):123-128.
• [8]Stagno S, Britt W: Cytomegalovirus. In Infectious Disease of the Fetus and Newborn Infant. Edited by Remington JS, Kelin JO, Wilson CB, Baker CJ. Philadelphia, PA: Wb Saunders Co; 2006:739-781.
• [9]Maine GT, Lazzarotto T, Landini MP: New developments in the diagnosis of maternal and congenital CMV infection. Expert Rev Mol Diagn 2001, 1(1):19-29.
• [10]Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ: National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 2011, 18(11):1895-1899.
• [11]ACOG: Perinatal viral and parasitic infections. ACOG practice bulletin 2000, 20:1-13.
• [12]Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, et al.: Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can 2010, 32(4):348-354.
• [13]Center for Disease Control and Prevention (CDC): Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy--United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(3):65-68.
• [14]Jeon J, Victor M, Adler SP, Arwady A, Demmler G, Fowler K, Goldfarb J, Keyserling H, Massoudi M, Richards K, et al.: Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol 2006, 2006:80383.
• [15]Korver AMH, de Vries JJC, de Jong JW, Dekker FW, Vossen ACTM, Oudesluys-Murphy AM: Awareness of congenital cytomegalovirus among doctors in the Netherlands. J Clin Virol 2009, 46(Suppl 4):S11-S15.
• [16]Ross DS, Victor M, Sumartojo E, Cannon MJ: Women's knowledge of congenital cytomegalovirus: results from the 2005 HealthStyles TM survey. Journal of Womens Health 2008, 17(5):849-858.
• [17]Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353(13):1350-1362.
• [18]Revello MG, IRCCS Policlinico S Matteo: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection (CHIP). http://clinicaltrials.gov/ct2/show/record/NCT00881517 webcite
• [19]Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV). http://clinicaltrials.gov/ct2/show/NCT01376778 webcite
• [20]Lazzarotto T, Guerra B, Gabrielli L, Lanari M, Landini MP: Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 2011, 17(9):1285-1293.
• [21]Thomson Reuters [Healthcare] Inc: MarketScan Databases User Guide and Database Dictionary. Ann Arbor, MI: Thomson Reuters [Healthcare] Inc; 2009.
• [22]Luzuriaga K, Sullivan JL: Infectious mononucleosis. N Engl J Med 2010, 362(21):1993-2000.
• [23]Rodriguez-Bano J, Muniain MA, Borobio MV, Corral JL, Ramirez E, Perea EJ, Perez-Cano R: Cytomegalovirus mononucleosis as a cause of prolonged fever and prominent weight loss in immunocompetent adults. Clin Microbiol Infect 2004, 10(5):468-470.
• [24]Routine Tests in Pregnancy [Educational Pamphlet AP133]. http://www.acog.org/publications/patient_education/bp133.cfm webcite
• [25]Cahill A, Odibo A, Macones G: 649: Screening and treating for prevention of congenital cytomegalovirus: what are we doing? [abstract]. Am J Obstet Gynecol 2009, 201(6):S236.
• [26]Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, et al.: Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 2011, 50(4):303-307.
• [27]Schlesinger Y: Routine screening for CMV in pregnancy: opening the pandora box? Israel Medical Association Journal 2007, 9(5):395-397.
• [28]Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Chatelet I, Senat MV, Frydman R, Grangeot-Keros L: Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009, 46:S49-S53.
• [29]Hyde TB, Schmid DS, Cannon MJ: Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010, 20(5):311-326.
• [30]Income, Poverty, and Health Insurance Coverage in the United States. 2009. http://www.census.gov/prod/2010pubs/p60-238.pdf webcite
• [31]Buchmueller TC, Monheit AC: Employer-sponsored health insurance and the promise of health insurance reform. Inquiry 2009, 46(2):187-202.
• [32]Cannon MJ: Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009, 46:S6-S10.
• [33]Feig DS, Razzaq A, Sykora K, Hux JE, Anderson GM: Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996–2001. Diabetes Care 2006, 29(2):232-235.
• [34]Tao G, Patterson E, Lee LM, Sansom S, Teran S, Irwin KL: Estimating prenatal syphilis and HIV screening rates for commercially insured women. Am J Prev Med 2005, 28(2):175-181.